Executive Summary
This $12.8B batch of 28 high-value federal contracts (> $5M) is overwhelmingly bullish (22/28), led by NASA's $7.0B+ in long-term space propulsion and R&D awards to Northrop Grumman ($4.4B), Boeing ($1.2B), L3Harris ($1.0B), and Lockheed Martin ($295M total), signaling multi-decade revenue stability through 2048 for aerospace primes. IT/services firms like Accenture ($1.6B total), CACI ($960M), and Booz Allen ($860M) capture steady revenue in education, VA, and intel support, with construction (Hensel Phelps $755M) adding infrastructure exposure. Neutral signals limited to nonprofits/small firms with minimal equity impact; risks center on long tenors (avg. 10+ years) and subaward dependencies exceeding 50% in several cases.
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from January 15, 2026.
Investment Signals(3)
- NASA Space Mega-Contracts Lock In Decade+ Revenue(HIGH)▲
Top 4 contracts total $7.0B+ to Northrop, Boeing, L3Harris, Lockheed for propulsion/R&D extending to 2048, with $1.9B already outlayed vs. $2B+ unexercised options.
- IT Services Dominate Civilian Agencies(HIGH)▲
Accenture ($1.6B total), CACI ($960M), Booz Allen ($860M), ECS ($528M potential) secure Title IV, VA EHRM, intel analysis contracts through 2027+, with $1.3B outlayed.
- VA/HHS Construction & Health IT Surge(MEDIUM)▲
Hensel Phelps ($755M NIH build to 2029), Novitas ($446M CMS to 2028), VA awards ($237M+ GDIT, $860M Booz) highlight infrastructure/health processing investments.
Risk Flags(3)
- Execution[HIGH RISK]▼
Long tenors (17 contracts to 2026+, 4 to 2030+) expose to funding shifts/delays; 12/28 have <$100M outlayed vs. obligations, e.g., L3Harris $93M of $1B.
- Execution[MEDIUM RISK]▼
Subawards >50% of value in 10 contracts (e.g., Booz Allen 97%, GDIT $294M>obligation), risking subcontractor delays/costs.
- Market[MEDIUM RISK]▼
Firm-fixed-price in 12 contracts (e.g., Hensel Phelps $755M, Accenture Ed $1.5B) bears full overrun risk amid inflation/labor shortages.
Opportunities(3)
- ◆
$3B+ unexercised options across 20 contracts (e.g., Lockheed GEOXO $2B potential, CACI $1.5B, ECS $429M ceiling)
- ◆
Small/disadvantaged biz wins (12 contracts, $600M+ total) in IT/construction (e.g., Serrato $43M DOL, Dawes $47M VA) signal set-aside pipeline scaling.
- ◆
Near-complete outlays in mature contracts (e.g., Accenture Ed $911M/1.5B, Hensel $447M/755M) provide backlog conversion visibility.
Sector Themes(3)
- ◆
$7B+ awards (55% of total value) to 4 primes for SLS/GEO/DAVINCI through 2048 emphasize sustained human spaceflight funding.
- ◆
25% of value in VA/DHS/DOI/SSA IT (EHRM, immigration, student aid) with extensions to 2032 signals cybersecurity/digital transformation spend.
- ◆
HHS/VA/DOI $1.5B+ in CMS processing, NIH/VAMC construction to 2029 reflects post-pandemic facility upgrades.
Watch List(3)
- 👁
{"entity"=>"Northrop Grumman", "reason"=>"$4.4B NASA propulsion (23% of batch value) with $958M outlayed but 2026 end risks program shifts.", "trigger"=>"Ares/SLS funding announcements"}
- 👁
{"entity"=>"Lockheed Martin", "reason"=>"Two NASA wins totaling $295M ($2.3B options) for GEOXO/DAVINCI to 2048 offer massive upside.", "trigger"=>"GEO XO option exercise >$500M"}
- 👁
{"entity"=>"Small Biz IT/Construction (Serrato, Dawes, EKAGRA)", "reason"=>"$200M+ cluster with set-asides and 80%+ outlay progress signals M&A/growth targets.", "trigger"=>"DOL/VA follow-on awards >$50M"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 28 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC